Addiction treatment in Louisiana

Making sense of addiction treatment in Louisiana starts with a simple fact: 366 licensed facilities exist, but they are not interchangeable. This guide walks through how to think about them — what matters clinically, what matters financially, and what families consistently wish they had known sooner.

The Medicaid question

Medicaid is worth understanding first because it shapes everything downstream. Louisiana expanded Medicaid in 2016 under the Affordable Care Act. In practical terms: has realistic access to Medicaid coverage for addiction treatment once enrolled. Whether you are Medicaid-eligible or using commercial insurance, the state's Medicaid posture affects provider-network composition, which affects what is actually reachable.

The overdose-mortality context

Louisiana's overdose mortality stands at 55.9 per 100,000 per recent CDC data. The clinical implications are specific: naloxone saturation, MAT access for opioid use disorder, and integrated behavioral-health capacity for the increasingly common stimulant-plus-fentanyl presentation. parish-level variation in MAT availability and licensing oversight

How access actually works in Louisiana

Operationally, working through Louisiana's 366 facilities requires a method. The productive sequence: start with insurance benefits verification, narrow to in-network facilities within reasonable travel distance, then filter by clinical-framework alignment (ASAM 4e) and MAT availability. Skipping the benefits step produces most of the post-admission financial disputes.

What to do next

For most families in Louisiana, the sequence that works: (1) honest self-assessment; (2) clinical assessment by someone with no commercial interest in admission; (3) insurance benefits verification in writing; (4) facility selection against clinical criteria. Reversing this order is the most common path to misalignment.